Indrayani Biotech Ltd — Important, 19-12-2025: Company Update

Indrayani Biotech's board approved the financial results for the quarter and half-year ended September 30, 2025. Consolidated total income was 37.75 Cr for the quarter and 67.91 Cr for the half-year, with a net loss of 1.57 Cr and 10.61 Cr, respectively. Standalone results showed total income of 13.02 Cr for the quarter and 27.52 Cr for the half-year, with a net profit of 0.60 Cr and 0.65 Cr, respectively. The board noted a director's resignation, leading to the reconstitution of the Nomination & Remuneration and Stakeholders Relationship Committees. A non-compliance fine from BSE for a delayed officer appointment was also addressed and paid.